{"filings":[{"id":95221,"accession_number":"0001628280-26-030552","cik":1756655,"company_name":"Ardent Health, Inc.","ticker":"ARDT","form_type":"8-K","filed_at":"2026-05-05T23:59:59+00:00","items":["2.02","9.01"],"status":"ready","headline":"Ardent Health Q1 2026: Revenue $1.60B (+7%), Adjusted EBITDA $124M (+26%), Reaffirms FY Guidance","event_type":"earnings","confidence":"high","bullets":["Total revenue $1.602B (+7.0% YoY); net income $40M ($0.28 diluted EPS) vs $41M ($0.29) a year ago.","Adjusted EBITDA $124M (+26.3% YoY); excluding $10.9M gain, growth was 15%.","Adjusted admissions +2.0%, total surgeries +1.2%; admissions -1.1% due to severe weather and light respiratory season.","Reaffirmed FY2026 guidance: revenue $6.4–$6.7B, Adj EBITDA $485–$535M, diluted EPS $0.90–$1.27.","Lease-adjusted net leverage improved to 2.6x from 3.0x a year ago; cash $610M, total debt $1.1B."],"consensus_eps_estimate":null,"consensus_eps_actual":0.28,"consensus_revenue_estimate":null,"consensus_revenue_actual":1601870000.0,"consensus_period":"2026-Q1","consensus_source":"xbrl_only","sentiment":"positive","materiality_score":0.7,"daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":108122,"accession_number":"0001628280-26-021738","cik":1756655,"company_name":"Ardent Health, Inc.","ticker":"ARDT","form_type":"8-K","filed_at":"2026-03-27T23:59:59+00:00","items":["5.02"],"status":"ready","headline":"President of Hospital Services Ethan Chernin leaves Ardent Health on March 24, 2026","event_type":"leadership","confidence":"high","bullets":["Ethan Chernin ceased as President, Hospital Services effective March 24, 2026.","Departure treated as a Qualifying Termination under the Executive Severance Plan.","Chernin eligible for severance benefits per terms described in prior SEC filings.","No replacement named for the President, Hospital Services role at this time."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.45,"daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":108121,"accession_number":"0001628280-26-014640","cik":1756655,"company_name":"Ardent Health, Inc.","ticker":"ARDT","form_type":"8-K","filed_at":"2026-03-04T23:59:59+00:00","items":["2.02","9.01"],"status":"ready","headline":"Ardent Health Q4 adj EBITDA down 26.6% to $134M; 2026 guidance issued","event_type":"earnings","confidence":"high","bullets":["Q4 total revenue $1.605B (flat YoY); net income $45M vs $114M prior year.","Q4 adjusted EBITDA $134M (down 26.6% YoY) due to annualization of prior-year benefits.","Full-year 2025 revenue $6.32B (+6%); adjusted EBITDA $545M (+9.3%); margin +20bps to 8.6%.","2026 guidance: revenue $6.4B-$6.7B, adjusted EBITDA $485M-$535M, reflecting headwinds.","Net leverage improved to 0.8x; operating cash flow $471M (+49% YoY); share buyback $3M in Q4."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"negative","materiality_score":0.75,"daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":124532,"accession_number":"0001628280-25-052879","cik":1756655,"company_name":"Ardent Health, Inc.","ticker":"ARDT","form_type":"8-K","filed_at":"2025-11-18T23:59:59+00:00","items":["7.01","2.03","9.01"],"status":"ready","headline":"Ardent Health authorizes $50M share repurchase program; $609M cash on hand","event_type":"other_material","confidence":"high","bullets":["Board authorized up to $50M in common stock repurchases; no expiration date.","CEO Marty Bonick cites conviction in business fundamentals and strong balance sheet.","Q3 2025 liquidity: $609M cash, lease-adjusted net leverage of 2.5x.","Program funded from existing cash; does not affect ability to pursue M&A or growth."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"positive","materiality_score":0.6,"daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":124531,"accession_number":"0001628280-25-051634","cik":1756655,"company_name":"Ardent Health, Inc.","ticker":"ARDT","form_type":"8-K","filed_at":"2025-11-12T23:59:59+00:00","items":["2.02","9.01"],"status":"ready","headline":"Ardent Health Q3 net loss $23M; cuts 2025 adj. EBITDA guidance to $530-555M","event_type":"earnings","confidence":"high","bullets":["Revenue $1.58B (+8.8% YoY); net loss attributable of $23M vs net income $26M in Q3 2024.","Adjusted EBITDA $143M (+46.3% YoY); excludes $43M revenue cut from accounting estimate change.","Professional liability reserves increased by $54M from adverse New Mexico claims (single provider, 2019-2022).","2025 adj. EBITDA guidance revised down to $530-555M (prior $575-615M) on higher professional fees & payor denials.","Workforce optimization, contract renegotiations launched to mitigate pressures; liquidity $904M, net leverage 1.0x."],"consensus_eps_estimate":null,"consensus_eps_actual":0.64,"consensus_revenue_estimate":null,"consensus_revenue_actual":4719260000.0,"consensus_period":"2025-Q3","consensus_source":"xbrl_only","sentiment":"negative","materiality_score":0.85,"daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":141216,"accession_number":"0001628280-25-042486","cik":1756655,"company_name":"Ardent Health, Inc.","ticker":"ARDT","form_type":"8-K","filed_at":"2025-09-23T23:59:59+00:00","items":["1.01","2.03","9.01"],"status":"ready","headline":"Ardent Health amends $777.5M term loan facility; rate cut 50 bps, maturity extended to 2032","event_type":"debt","confidence":"high","bullets":["Interest rate reduced by 50 bps to Term SOFR + 2.25%; expected annual interest savings of ~$3.9M.","Maturity extended from August 2028 to September 2032, enhancing financial flexibility.","ABL credit agreement also amended to align covenant baskets; no material changes or maturity extension.","CFO Alfred Lumsdaine cites continued confidence of lending partners and support for growth strategy."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"positive","materiality_score":0.6,"daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":141215,"accession_number":"0001756655-25-000013","cik":1756655,"company_name":"Ardent Health, Inc.","ticker":"ARDT","form_type":"8-K","filed_at":"2025-08-05T23:59:59+00:00","items":["2.02","9.01"],"status":"ready","headline":"Ardent Health Q2 revenue up 12% to $1.65B; Adj EBITDA +39% to $170M; reaffirms FY25 guidance","event_type":"earnings","confidence":"high","bullets":["Net income $73M ($0.52 diluted EPS) vs $43M ($0.34) prior year; adjusted EBITDA $170M.","Total revenue $1.645B (+11.9% YoY) driven by 1.6% adjusted admission growth and 10.2% revenue per adjusted admission.","Admissions +6.6% YoY; inpatient surgeries +9.2% but outpatient surgeries -3.8%.","Lease-adjusted net leverage ratio improved to 2.7x from 3.0x in Q1; available liquidity $835M.","Reaffirms FY25 guidance: revenue $6.2-6.45B, Adj EBITDA $575-615M, diluted EPS $1.73-2.01."],"consensus_eps_estimate":null,"consensus_eps_actual":0.81,"consensus_revenue_estimate":null,"consensus_revenue_actual":3142514000.0,"consensus_period":"2025-Q2","consensus_source":"xbrl_only","sentiment":"positive","materiality_score":0.8,"daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":159021,"accession_number":"0001756655-25-000009","cik":1756655,"company_name":"Ardent Health, Inc.","ticker":"ARDT","form_type":"8-K","filed_at":"2025-06-20T23:59:59+00:00","items":["5.02"],"status":"ready","headline":"Ardent Health President of Hospital Operations David Schultz Departs","event_type":"leadership","confidence":"high","bullets":["David Schultz no longer serves as President, Hospital Operations, effective June 16, 2025.","Departure treated as a 'Qualifying Termination' under the company's Executive Severance Plan.","Schultz eligible for severance benefits per plan terms; no replacement named."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.5,"daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":159020,"accession_number":"0001628280-25-027604","cik":1756655,"company_name":"Ardent Health, Inc.","ticker":"ARDT","form_type":"8-K","filed_at":"2025-05-23T23:59:59+00:00","items":["5.03","5.07","9.01"],"status":"ready","headline":"Ardent Health Partners changes name to Ardent Health, Inc. effective June 3, 2025","event_type":"other","confidence":"high","bullets":["Name change to Ardent Health, Inc.; effective June 3, 2025; NYSE ticker ARDT unchanged.","Board approved amendment; stockholder approval not required under Delaware law.","Annual meeting on May 21, 2025: 11 directors elected; say-on-pay approved with ~98.8% for.","Say-on-pay frequency set to annual until next vote; Ernst & Young ratified as auditor for FY2025.","No change to stockholder rights, CUSIP number, or trading symbol."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.2,"daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null}],"next_cursor":null}